Genetic aspects of growth hormone deficiency

J. Argente Oliver, Luis Perez-Jurado

Research output: Contribution to journalReview article

Abstract

Congenital deficiency in growth hormone (GH) secretion generates a deficiency in IGF-I and, therefore, a pathologically decreased growth rate that leads to the acquisition of low height that should be adequately diagnosed and treated so that the height that the patient can acquire as an adult will be similar to that which his or her intact genetic potential would provide. Up to now, molecular biology techniques have made it possible to diagnose biologically inactive GH molecules and deletions or mutations of different genes: GH, hypothalamic GH releasing hormone receptor (GHRHr), hypophyseal transcription factor number 1 (Pit1), Prop transcription factor number 1 (Prop 1) and Hesx1 transcription factor. Imaging techniques, especially nuclear magnetic resonance, have efficaciously contributed to the diagnosis of abnormalities in the morphology of the hypophysis (agenesis, aplasia, hypoplasia) and the parasellar region present in patients with GH deficiencies due to genetic abnormalities.

Translated title of the contributionGenetic aspects of growth hormone deficiency
LanguageSpanish
Pages397-407
Number of pages11
JournalRevista Espanola de Pediatria
Volume55
Issue number329
Publication statusPublished - 1999
Externally publishedYes

Keywords

  • Genes: GH1
  • GHRHr
  • Hesx1
  • IGF-1
  • Pit1
  • Prop1

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

@article{1011b9ddebbf466ca94af3bf5c3133c4,
title = "Aspectos geneticos de la deficiencia de hormona de crecimiento",
abstract = "Congenital deficiency in growth hormone (GH) secretion generates a deficiency in IGF-I and, therefore, a pathologically decreased growth rate that leads to the acquisition of low height that should be adequately diagnosed and treated so that the height that the patient can acquire as an adult will be similar to that which his or her intact genetic potential would provide. Up to now, molecular biology techniques have made it possible to diagnose biologically inactive GH molecules and deletions or mutations of different genes: GH, hypothalamic GH releasing hormone receptor (GHRHr), hypophyseal transcription factor number 1 (Pit1), Prop transcription factor number 1 (Prop 1) and Hesx1 transcription factor. Imaging techniques, especially nuclear magnetic resonance, have efficaciously contributed to the diagnosis of abnormalities in the morphology of the hypophysis (agenesis, aplasia, hypoplasia) and the parasellar region present in patients with GH deficiencies due to genetic abnormalities.",
keywords = "Genes: GH1, GHRHr, Hesx1, IGF-1, Pit1, Prop1",
author = "{Argente Oliver}, J. and Luis Perez-Jurado",
year = "1999",
language = "Spanish",
volume = "55",
pages = "397--407",
journal = "Revista Espanola de Pediatria",
issn = "0034-947X",
publisher = "Ediciones Ergon SA",
number = "329",

}

Aspectos geneticos de la deficiencia de hormona de crecimiento. / Argente Oliver, J.; Perez-Jurado, Luis.

In: Revista Espanola de Pediatria, Vol. 55, No. 329, 1999, p. 397-407.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Aspectos geneticos de la deficiencia de hormona de crecimiento

AU - Argente Oliver, J.

AU - Perez-Jurado, Luis

PY - 1999

Y1 - 1999

N2 - Congenital deficiency in growth hormone (GH) secretion generates a deficiency in IGF-I and, therefore, a pathologically decreased growth rate that leads to the acquisition of low height that should be adequately diagnosed and treated so that the height that the patient can acquire as an adult will be similar to that which his or her intact genetic potential would provide. Up to now, molecular biology techniques have made it possible to diagnose biologically inactive GH molecules and deletions or mutations of different genes: GH, hypothalamic GH releasing hormone receptor (GHRHr), hypophyseal transcription factor number 1 (Pit1), Prop transcription factor number 1 (Prop 1) and Hesx1 transcription factor. Imaging techniques, especially nuclear magnetic resonance, have efficaciously contributed to the diagnosis of abnormalities in the morphology of the hypophysis (agenesis, aplasia, hypoplasia) and the parasellar region present in patients with GH deficiencies due to genetic abnormalities.

AB - Congenital deficiency in growth hormone (GH) secretion generates a deficiency in IGF-I and, therefore, a pathologically decreased growth rate that leads to the acquisition of low height that should be adequately diagnosed and treated so that the height that the patient can acquire as an adult will be similar to that which his or her intact genetic potential would provide. Up to now, molecular biology techniques have made it possible to diagnose biologically inactive GH molecules and deletions or mutations of different genes: GH, hypothalamic GH releasing hormone receptor (GHRHr), hypophyseal transcription factor number 1 (Pit1), Prop transcription factor number 1 (Prop 1) and Hesx1 transcription factor. Imaging techniques, especially nuclear magnetic resonance, have efficaciously contributed to the diagnosis of abnormalities in the morphology of the hypophysis (agenesis, aplasia, hypoplasia) and the parasellar region present in patients with GH deficiencies due to genetic abnormalities.

KW - Genes: GH1

KW - GHRHr

KW - Hesx1

KW - IGF-1

KW - Pit1

KW - Prop1

UR - http://www.scopus.com/inward/record.url?scp=0032748770&partnerID=8YFLogxK

M3 - Review article

VL - 55

SP - 397

EP - 407

JO - Revista Espanola de Pediatria

T2 - Revista Espanola de Pediatria

JF - Revista Espanola de Pediatria

SN - 0034-947X

IS - 329

ER -